83 related articles for article (PubMed ID: 2104432)
1. [Evaluation of the anti-arrhythmia effectiveness of Phenazolinum Polfa in paroxysmal atrial fibrillation].
Srzednicki M; Sadowski Z; Kulikowski A
Pol Tyg Lek; 1990 Nov 5-12; 45(45-46):924-7. PubMed ID: 2104432
[No Abstract] [Full Text] [Related]
2. The effectiveness and timing of elective pharmacological cardioversion for paroxysmal atrial fibrillation.
Shah DC
Eur Heart J; 1999 Dec; 20(24):1768-9. PubMed ID: 10581132
[No Abstract] [Full Text] [Related]
3. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
[TBL] [Abstract][Full Text] [Related]
4. [Drug treatment of auricular fibrillation].
Adamski M; Kontek M
Pol Tyg Lek; 1981 Mar; 36(11):401-4. PubMed ID: 7267408
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of antazoline in the rapid cardioversion of paroxysmal atrial fibrillation (the AnPAF Study).
Maciag A; Farkowski MM; Chwyczko T; Beckowski M; Syska P; Kowalik I; Pytkowski M; Wozniak J; Dabrowski R; Szwed H
Europace; 2017 Oct; 19(10):1637-1642. PubMed ID: 28339554
[TBL] [Abstract][Full Text] [Related]
6. Effect of antiarrhythmic therapy with intravenous loading dose of amiodarone: evidence for an altered response in diabetic patients.
Iervasi G; Clerico A; Bonini R; Nannipieri M; Manfredi C; Sabatino L; Biagini A; Donato L
Int J Clin Pharmacol Res; 1998; 18(3):109-20. PubMed ID: 9825267
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of anti-arrhythmia agents in atrial fibrillation paroxysms].
Anshelevich IuV; Sorokina TA; Bekere FA; Slaĭdyn' AK; Beer ET
Klin Med (Mosk); 1980 Jun; 58(6):43-6. PubMed ID: 7401602
[No Abstract] [Full Text] [Related]
8. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.
Roy D; Rowe BH; Stiell IG; Coutu B; Ip JH; Phaneuf D; Lee J; Vidaillet H; Dickinson G; Grant S; Ezrin AM; Beatch GN;
J Am Coll Cardiol; 2004 Dec; 44(12):2355-61. PubMed ID: 15607398
[TBL] [Abstract][Full Text] [Related]
9. Letter by Reiffel regarding article, "Acute pharmacological conversion of atrial fibrillation to sinus rhythm".
Reiffel JA
Circulation; 2009 Jan; 119(3):e17; author reply e18. PubMed ID: 19171861
[No Abstract] [Full Text] [Related]
10. Electrophysiological mechanism of combination therapy with disopyramide and propranolol for paroxysmal atrial fibrillation.
Gondo N; Kumagai K; Yamanouchi Y; Annoura M; Saku K
J Cardiol; 2000 Dec; 36(6):405-10. PubMed ID: 11190584
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of atrial fibrillation. Heart rate control is primary goal].
MMW Fortschr Med; 2002 Oct; 144(40):48. PubMed ID: 12440299
[No Abstract] [Full Text] [Related]
12. [The use of digitalis glycosides in atrial fibrillation].
Knez A; Haberl R; Steinbeck G
Z Kardiol; 1994; 83 Suppl 5():71-3. PubMed ID: 7846948
[TBL] [Abstract][Full Text] [Related]
13. Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial.
Madonia S; De Simone M; Brai G; Gozzo D; Gristina A; Luciano L; Maisano S; Migliore G; Mineo R; Muzzo MP; Nicchi F; Randazzo A; Raspanti G; Rotolo G; Russo A; Sagona F; Schirosa M; Spinello M; Stancampiano R; Geraci E
Ital Heart J; 2000 Jul; 1(7):475-9. PubMed ID: 10933330
[TBL] [Abstract][Full Text] [Related]
14. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
[TBL] [Abstract][Full Text] [Related]
15. Drug therapy for atrial fibrillation.
Conway EL; Musco S; Kowey PR
Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the beta receptor affecting substance Iproveratril on heart rate and arrhythmia].
Hofmann H
Z Gesamte Inn Med; 1969 Sep; 24(17):561-7. PubMed ID: 4393852
[No Abstract] [Full Text] [Related]
17. Shedding new light on the pathophysiology of conversion of paroxysmal atrial fibrillation into persistent atrial fibrillation.
Homoud MK; Estes M
Am Heart J; 2007 Nov; 154(5):801-4. PubMed ID: 17967581
[No Abstract] [Full Text] [Related]
18. Pseudo-cardioversion of atrial fibrillation.
Cheng TO
Int J Cardiol; 2005 May; 101(2):305. PubMed ID: 15882680
[No Abstract] [Full Text] [Related]
19. [Programmed esophageal stimulation of the atrium and the long-term effects of anti-arrhythmia therapy of atrial fibrillation and flutter].
Novotný E; Uhrová V; Suda J
Vnitr Lek; 1995 Sep; 41(9):586-9. PubMed ID: 7483347
[TBL] [Abstract][Full Text] [Related]
20. [Electrophysiologic effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation].
Chimienti M; Moizi M; Salerno JA; Klersy C; Marangoni E; Previtali M; Montemartini C; Bobba P
Cardiologia; 1986 Feb; 31(2):155-61. PubMed ID: 3098424
[No Abstract] [Full Text] [Related]
[Next] [New Search]
